BioMarker Ltd. – 30 Years at the Forefront of Diagnostic Innovation

HU 


Since its founding in 1996, BioMarker Ltd. has been driven by a single mission: to bring the world’s leading diagnostic and research technologies to Hungary. Over the past three decades, we have grown into one of the country’s most influential professional and commercial representatives, serving as the exclusive partner of global high-tech manufacturers.
Our product portfolio spans the full spectrum of modern laboratory operations—from clinical diagnostics and life sciences to industrial testing. Whether it is high-capacity automated systems or specialized research reagents, every solution we deliver is backed by world-class technology and expert support.
Our nationwide service network, application specialists and product managers work side by side with our partners every day, ensuring fast, precise, and personalized assistance in every situation.

Our Key Market Segments

  • Clinical diagnostics
  • Pathology and histology
  • Life-science research
  • Industrial material and purity analysis
  • Molecular diagnostics
  • Food safety
  • Veterinary diagnostics
  • Forensic human identification
     

Leica Biosystems & Leica Microsystems – Innovation Shaping the Future of Pathology

Since February 1, 2008, BioMarker Ltd. has been the exclusive Hungarian representative for Leica Biosystems and Leica Microsystems across their full healthcare portfolio. This partnership, now spanning more than twenty years, is built on continuous technological advancement and a deep commitment to diagnostic excellence.
Leica offers one of the broadest and most rapidly evolving pathology and histology portfolios in the world. Their high-capacity automation platforms cover entire laboratory workflows, enabling the complete setup of hospital and research facility infrastructures.
Their philosophy is straightforward yet powerful: patients should receive accurate diagnoses as quickly as possible. Leica’s innovations—central to the rise of digital pathology—continue to define the global future of diagnostic medicine.
Their portfolio is further strengthened by KREATECH’s Repeat-Free FISH technology, where we bring nearly a decade of experience supporting partners from hematopathology to cytogenetics.
Complementary reagents from BioSB (USA), VECTOR Laboratories, ENZO, Cayman, and Axxora/Alexis ensure flexible, comprehensive solutions for the diverse needs of histology and life-science research.

Molecular Biology, Life Sciences, Food Safety, Veterinary Medicine & Forensics – QIAGEN
 

QIAGEN, a pioneering German company, helped lay the foundations of modern molecular biology by creating the world’s first plasmid purification kit. Today, BioMarker Ltd. provides its highest-quality nucleic acid isolation, PCR, qPCR and cutting-edge digital PCR (dPCR) technologies to research and clinical laboratories nationwide.
QIAGEN’s solutions are indispensable in:

  • DNA-based HPV screening
  • Cervical cancer risk assessment using methylation analysis
  • Hungary’s nationwide latent tuberculosis program (Quantiferon TB)
  • NGS technology
  • Automated molecular biology solutions
  • Digital PCR solutions
  • Syndromic multiplex PCR based testing -QIAstst Dx

With its panel-based pathogen detection for syndromic testing, QIAstat delivers breakthrough speed in identifying infectious agents—whether in the laboratory or at the patient’s bedside.
 

SNIBE – The Laboratory of the Future, Available Today

Since 2025, we have been the exclusive distributor of SNIBE’s clinical diagnostic portfolio in Hungary. The Maglumi analyzer series sets a new benchmark in laboratory automation: compact design, intuitive use, and one of the widest test menus available on the global market.
What sets SNIBE apart:
 

  • Each reagent includes its own dedicated, optimized control and calibrator
  • Small kit sizes are also available and ensures cost-efficient operation
  • The 2025 TLA – Total Laboratory Automation system achieved rapid global success
  • The upcoming 2026 Hemoloumi analyzers will bring transformative advancements to haemostasis diagnostics
     

Dymind – A New Generation in Hematology

Since 2024, BioMarker Ltd. has been the exclusive professional and commercial representative of Dymind in Hungary. Their advanced hematology platforms open new possibilities for laboratories seeking fast, automated and exceptionally reliable blood diagnostics. Dymind technologies establish a new standard for modern hematology.
 

Committed to Your Success

At BioMarker Ltd., we believe that innovation becomes true value only when paired with expertise and dedicated support. This is what drives our work every day.
Our website showcases only part of our extensive portfolio. If you are seeking new diagnostic or research solutions, need guidance, or wish to explore our latest technologies, we welcome your inquiry.
Every collaboration begins with a question — and we are here to deliver the answer.